TLR2 and listeriosis: Already published data suggest long-term protection by trained innate immunity: two intra-peritoneal injections of 1 mg of the Toll-like receptor-2 agonist zymosan at an interval of 4 days protected mice from Listeria monocytogenes infections for 9 weeks (35).